PCOS and Getting Pregnant — What You Actually Need to Know
CalcPCOS Learning Center Fertility & Conception

PCOS and Getting Pregnant — What You Actually Need to Know

Updated July 2026 13 min read Evidence-based
Key takeaways
  • PCOS is the most common cause of ovulatory infertility — but it is also one of the most treatable. Most people with PCOS can conceive with appropriate intervention.
  • Letrozole is now the evidence-based first-line treatment for ovulation induction in PCOS — outperforming clomiphene citrate across multiple outcomes in large RCTs.
  • Lifestyle changes — particularly a 5–10% reduction in body weight in overweight individuals — can restore ovulation before any medication is needed.
  • IVF success rates in PCOS are comparable to or higher than the general infertility population — OHSS risk has been significantly reduced by modern protocols.
  • Nutrition and supplementation (vitamin D, inositol, CoQ10, folate) meaningfully improve treatment outcomes and should be started at least 3 months before fertility treatment.
  • PCOS pregnancies carry higher risks of gestational diabetes and hypertensive disorders — monitoring throughout pregnancy is important regardless of how conception occurred.

A PCOS diagnosis can feel like a fertility verdict — particularly if you've been told you "don't ovulate regularly" or that getting pregnant will be difficult. The reality is more nuanced and considerably more hopeful than that framing suggests.

PCOS is the leading cause of ovulatory infertility — accounting for approximately 80% of anovulatory infertility cases. But it is also one of the most treatable causes of infertility, with a range of effective interventions from lifestyle changes through to assisted reproduction. Most people with PCOS who want to conceive, can — the question is which approach is appropriate for their specific situation and how to optimise the conditions for success.

This guide covers the full picture — why PCOS affects fertility, the stepwise treatment approach, what lifestyle changes produce the best outcomes, realistic success rates by treatment, and how to prepare nutritionally for conception or fertility treatment.

80%
of anovulatory infertility is caused by PCOS — the most common single cause
80%
ovulation response rate to letrozole in PCOS — the current first-line treatment
42%
live birth rate per IVF cycle for PCOS patients — comparable to or above general population

Why PCOS affects fertility — the mechanism

PCOS affects fertility primarily through anovulation — the failure to ovulate regularly or at all. Understanding why this happens explains both what treatments address it and what lifestyle factors support its correction.

The core mechanism: elevated insulin levels (from insulin resistance, present in 65–70% of PCOS cases) stimulate the ovaries to produce excess androgens — particularly testosterone. Elevated testosterone interferes with normal follicle development, preventing any single follicle from reaching full maturity and releasing an egg. Multiple partially developed follicles remain in the ovary — the "cysts" visible on ultrasound that give PCOS its name — but ovulation does not occur.

Additionally, elevated LH (luteinising hormone) — common in PCOS — disrupts the LH surge required to trigger ovulation, and elevated prolactin (in some PCOS presentations) further suppresses ovulatory function. The result is irregular or absent ovulation, making conception difficult but not impossible — particularly with intervention that addresses the underlying hormonal disruption.

The important distinction

Irregular ovulation is not the same as no ovulation. Many people with PCOS ovulate — just unpredictably and less frequently than normal. This means natural conception is possible even without intervention, but the timing is difficult to predict. Ovulation tracking (basal body temperature, LH testing strips) can identify the cycles where ovulation does occur. Some people with PCOS conceive naturally; others need assistance to induce more regular ovulation.

The stepwise treatment approach — what happens and in what order

Managing infertility in PCOS requires an evidence-based, stepwise approach that balances effectiveness, safety, and patient preferences. Over the last decade, practice-changing trials and modern ART safety strategies have shifted first-line and ART protocols. Here is the current evidence-based pathway:

1
Lifestyle intervention — the first and most underused step
In overweight individuals with PCOS, a 5–10% reduction in body weight through dietary and exercise changes can restore spontaneous ovulation without any medication. This is the recommendation from the 2023 International PCOS Guideline as the first-line approach before pharmacological intervention — and it is consistently underutilised. Weight loss improves insulin sensitivity, reduces androgen production, and restores the hormonal environment for ovulation. Even if it doesn't produce spontaneous ovulation, it meaningfully improves the response to any subsequent treatment.
First line — all patients
2
Letrozole — first-line ovulation induction
Letrozole has become the first-line agent for ovulation induction in PCOS, having displaced clomiphene citrate (clomid) following the landmark NEJM Legro trial which showed letrozole produced significantly higher live birth rates (27.5% vs 19.1%) and ovulation rates than clomiphene in PCOS. Letrozole is an aromatase inhibitor — it temporarily reduces oestrogen, triggering FSH release which stimulates follicle development. It is taken orally for 5 days early in the cycle. An 80% ovulation response rate makes this the most effective first pharmacological option.
First-line pharmaceutical
3
Metformin — as adjunct or alternative
Metformin's metabolic action involves amelioration of insulin resistance, which helps resolve hormonal and metabolic disturbances and increases ovulation, pregnancy, and live birth rates relative to placebo. Metformin is used either alone (with lower ovulation rates than letrozole) or in combination with letrozole — the combination is more effective than letrozole alone in some populations, particularly those with significant insulin resistance. The combination of Metformin with clomiphene is also more effective than clomiphene alone in clomiphene-resistant PCOS.
Second line / adjunct
4
Gonadotropins — injectable ovulation induction
Gonadotropins are effective second-line agents for ovulation induction but increase monitoring needs and OHSS and multiple pregnancy risk; low-dose step-up regimens reduce but do not eliminate these harms. Injectable FSH stimulates follicle development more powerfully than oral agents but requires close ultrasound monitoring to prevent hyperstimulation (OHSS) and multiple pregnancy. Used when oral agents have failed or produce an insufficient response.
Second/third line
5
IVF — when other approaches haven't worked
In ART, GnRH antagonist stimulation protocols combined with GnRH-agonist trigger and selective "freeze-all"/deferred embryo transfer markedly reduce OHSS risk while maintaining comparable pregnancy outcomes. IVF is typically recommended after failed ovulation induction cycles, when there are additional infertility factors (tubal, male factor), or for those preferring to move directly to ART. Modern freeze-all protocols have dramatically reduced the OHSS risk that previously made PCOS patients higher-risk IVF candidates.
After failed earlier steps / direct choice

Treatment success rates — realistic numbers

Treatment Ovulation rate Pregnancy rate per cycle Key consideration
Lifestyle changes alone Variable — up to 60% restoration in overweight PCOS Dependent on ovulation restoration Most underutilised intervention. Most effective when BMI is above 27.
Letrozole ~80% ~27% per cycle First-line pharmaceutical. Higher live birth rate than clomiphene in PCOS. Usually tried for 3–6 cycles.
Clomiphene (Clomid) ~70–85% ~19% per cycle Historically first-line but now second to letrozole for PCOS specifically. Anti-oestrogenic effects on endometrium reduce implantation.
Letrozole + Metformin Higher than letrozole alone in high-IR patients Improved vs letrozole alone in selected populations Combination most effective in patients with significant insulin resistance. Standard practice in many centres.
Gonadotropins ~70–90% ~20% per cycle (with IUI) Requires intensive monitoring. Multiple pregnancy risk requires careful dose titration.
IVF (freeze-all protocol) N/A — retrieval-based ~42% live birth per cycle OHSS risk significantly reduced by modern protocols. PCOS patients often respond well — good egg numbers retrieved.
IUI alone N/A ~20% per cycle Only useful if ovulation is already occurring. Ineffective for anovulatory PCOS without concurrent ovulation induction.

Lifestyle changes that most affect PCOS fertility

⚖️
5–10% body weight reduction
The single most impactful lifestyle intervention for overweight PCOS patients. Improves insulin sensitivity, reduces androgens, and can restore spontaneous ovulation. Even a 5% reduction has documented effects on ovulation rate and menstrual regularity.
🥗
Low-carb, higher-protein diet
Reduces insulin levels — the primary driver of ovarian androgen excess. A Mediterranean or low-carb dietary pattern improves hormonal environment for ovulation. Start at least 3 months before attempting conception or fertility treatment.
🧘
Consistent moderate exercise
150–300 minutes per week of moderate aerobic activity improves insulin sensitivity and reduces visceral fat. Yoga specifically has the strongest evidence for both insulin resistance reduction and testosterone lowering — directly relevant to ovulation restoration.
😴
Sleep quality
Poor sleep worsens insulin resistance and cortisol dysregulation — both of which suppress ovulation. 7–9 hours of consistent sleep is not a lifestyle luxury during fertility preparation; it's a clinically relevant variable that affects hormonal regulation.
🧘
Stress management
Chronic stress elevates cortisol, which suppresses the HPO axis signalling required for ovulation. The stress of trying to conceive can itself create a cortisol burden that delays conception — mindfulness-based stress reduction, yoga, and adequate social support all have clinical relevance here.
🚭
Eliminate alcohol and smoking
Both worsen insulin resistance and impair ovarian function. Alcohol also worsens the liver's ability to clear oestrogen, potentially worsening hormonal imbalance. Both should be eliminated during conception attempts and fertility treatment — not just reduced.

Nutritional preparation — what to start before treatment

The quality of eggs developed during the 3–4 months before retrieval or natural conception is significantly influenced by nutritional status during that window. These are the most evidence-supported nutritional preparations for PCOS fertility:

  • Methylfolate (400–800 mcg/day) — start at least 3 months before attempting conception. Essential for neural tube development. Use methylfolate rather than standard folic acid if you have MTHFR gene variants (common in PCOS populations).
  • Vitamin D (test first, correct to 40–60 ng/mL) — deficiency is associated with lower ovulation rates, lower IVF success, and higher miscarriage risk. Correct deficiency before beginning treatment.
  • Inositol (4,000 mg MYO + 100 mg DCI) — the supplement with the strongest PCOS-specific fertility evidence. Start 3 months before planned IVF for egg quality benefit.
  • CoQ10 (200–600 mg ubiquinol) — particularly relevant over 30. Supports mitochondrial function in developing eggs. Start 3 months before IVF retrieval for meaningful impact on egg quality.
  • Omega-3 EPA+DHA (1,000–2,000 mg) — anti-inflammatory and supports ovarian function. Important for the developing embryo post-conception.
  • Vitamin B12 (1,000 mcg methylcobalamin) — if on Metformin, annual testing is essential and supplementation likely needed. B12 deficiency impairs ovulation and early embryo development.
The 3-month rule

Egg development (folliculogenesis) takes approximately 90 days from primordial follicle to mature oocyte ready for release. Nutritional changes and supplements started 3 months before conception attempts or IVF retrieval have the opportunity to influence the quality of the eggs that will be retrieved or ovulated. Changes started the week before treatment have no meaningful impact on egg quality — the 3-month window is mechanistically real, not an arbitrary recommendation.

OHSS — the main IVF risk in PCOS and how it's managed now

Ovarian Hyperstimulation Syndrome (OHSS) — a potentially serious overresponse to fertility medications — was historically a significant concern for PCOS patients in IVF, because PCOS ovaries tend to respond vigorously to stimulation hormones. This risk has been dramatically reduced by modern protocols.

GnRH antagonist stimulation protocols combined with GnRH-agonist trigger and selective "freeze-all"/deferred embryo transfer markedly reduce OHSS risk while maintaining comparable pregnancy outcomes. The "freeze-all" approach — freezing all embryos rather than doing a fresh transfer — eliminates the period immediately after retrieval when OHSS typically develops and worsens, while achieving equivalent or better pregnancy rates through subsequent frozen transfers.

If you are considering IVF with PCOS, ask your clinic specifically about their OHSS mitigation protocol. The use of a GnRH antagonist protocol, GnRH agonist trigger, and freeze-all strategy is now considered best practice for PCOS patients.

What to expect — a realistic fertility timeline

3M
3 months before trying — preparation window
Start folate supplementation, correct vitamin D deficiency, begin inositol and CoQ10. Start lifestyle changes — dietary and exercise — if needed. Request fasting insulin and vitamin D tests from your GP if not already done. This window matters most for egg quality.
M1
Month 1 of trying — tracking and baseline
Use LH testing strips and basal body temperature tracking to identify if and when ovulation occurs. PCOS cycles can be long (35–90+ days) — tracking helps identify the ovulatory window. An appointment with a reproductive endocrinologist at this stage is reasonable, particularly if cycles are very irregular.
6M
After 6 months of trying — first specialist appointment
Standard guidance is to seek specialist advice after 12 months for women under 35 and 6 months for those 35 and over. For PCOS with confirmed irregular ovulation, seeking advice after 6 months is reasonable regardless of age — because the issue is likely anovulation, not bad timing, and ovulation induction is straightforward to initiate.
OI
Ovulation induction cycles — letrozole
Most reproductive endocrinologists will try 3–6 cycles of letrozole before moving to the next step. Each cycle has an approximately 27% chance of resulting in pregnancy — cumulative success rates across 6 cycles are meaningfully higher. Monitoring via ultrasound confirms follicle development and ovulation.
IVF
IVF — if ovulation induction is unsuccessful
PCOS patients typically respond well to IVF stimulation — often producing a good number of eggs. Modern freeze-all protocols reduce OHSS risk substantially. IVF success rates for PCOS patients are approximately 42% live birth per cycle — comparable to or above the general infertility population at equivalent ages.

PCOS pregnancy — what to know after conception

Conceiving with PCOS is one milestone — but PCOS pregnancies carry specific risks that require monitoring throughout:

  • Gestational diabetes — significantly more common in PCOS pregnancies due to pre-existing insulin resistance. All PCOS pregnancies should be screened early (typically at 24–28 weeks, sometimes earlier).
  • Hypertensive disorders (gestational hypertension, pre-eclampsia) — elevated risk, particularly in PCOS with obesity. Blood pressure monitoring throughout pregnancy is important.
  • Miscarriage risk — elevated in PCOS, partly related to insulin resistance and elevated LH. Metformin continued to the end of the first trimester at an effective dose may help reduce the rate of miscarriage in PCOS — discuss with your OB-GYN whether continuing Metformin through the first trimester is appropriate for your situation.
  • Preterm birth — modestly elevated risk. Monitoring for cervical length and growth is more frequent in PCOS pregnancies at many centres.

None of these risks mean a PCOS pregnancy is high-risk in a dramatic sense — they mean monitoring is important. Most people with PCOS have uncomplicated pregnancies. The risks are elevated compared to the general population but are well-managed with appropriate antenatal care.

Frequently asked questions

Can I get pregnant naturally with PCOS?

Yes — many people with PCOS conceive naturally, particularly those who ovulate irregularly rather than never. If cycles are irregular, ovulation tracking can help identify the ovulatory window. If periods are very infrequent (fewer than 8 per year) or absent, natural conception is less likely without intervention — but ovulation induction is highly effective in this population.

Should I lose weight before trying to conceive with PCOS?

If your BMI is above 30, a 5–10% weight reduction before fertility treatment is generally recommended and significantly improves treatment outcomes. The decision for BMI between 25–30 is more nuanced and depends on age, timeline, and clinical picture — discuss with your reproductive endocrinologist. Do not pursue very aggressive weight loss during active fertility treatment.

Is letrozole or Clomid better for PCOS?

Letrozole. The evidence is now clear — letrozole produces higher live birth rates and ovulation rates than clomiphene citrate in PCOS specifically, and is the recommendation in all current international guidelines. If you have been prescribed clomiphene as the first-line agent for PCOS, it is worth asking your prescriber whether letrozole is available and appropriate for your situation.

How many IVF cycles does it typically take with PCOS?

PCOS patients generally respond well to IVF stimulation — often producing a good number of eggs per retrieval. A single retrieval cycle with a freeze-all protocol can produce multiple embryos for subsequent transfer, meaning the live birth rate cumulative across all transfers from one retrieval can be significantly higher than the per-cycle rate. The specific number depends heavily on age, ovarian reserve, and embryo quality.

Does inositol help with fertility in PCOS?

A 2025 systematic review found meaningful evidence for myo-inositol and DCI on ART outcomes in PCOS undergoing IVF — including improved fertilisation rates and embryo quality. Inositol is the supplement with the strongest PCOS-specific fertility evidence base. Start it at least 3 months before planned treatment for meaningful impact on egg quality and ovulation rate.

Get your fertility calorie and nutrient targets

Three fertility goals — optimise nutrition, lose weight first, or IVF/IUI prep — each with BMI-adjusted calorie targets, IR-adjusted carb limits, and eight key fertility nutrients with daily targets.

Open fertility calculator →

Sources & references IORO Publications (June 2026). From ovulation induction to IVF: a short review of fertility treatments for women with PCOS — narrative systematic approach through December 2024. · PMC (2025). Treatment options for managing anovulation in women with PCOS: extensive literature review of evidence-based recommendations. PMC12194079. · Human Reproduction Open (2024). Extended versus conventional letrozole regimen in PCOS: prospective RCT — confirming letrozole as first-line. · PMC (2025). Integrative approaches to ovulation induction in PCOS: narrative review — robust evidence supports letrozole as first-line. PMC41301804. · Legro RS et al. (2014). Letrozole versus clomiphene for infertility in PCOS. NEJM. — landmark trial showing 27.5% vs 19.1% live birth rates. · Brand KMG et al. (2025). Update on the therapeutic role of Metformin in PCOS — ovulation and pregnancy outcomes. Women's Health, PMC11792029. · Akbari Sene A et al. (2025). Effect of myo-inositol on ART outcomes in PCOS: systematic review and meta-analysis. PMC12413536. · Kriplani et al. (2024). Phase III RCT: Metformin plus myo-inositol vs Metformin alone in PCOS. Cureus, PMC11725314. · PCOS Guide (2026). PCOS fertility success rate analysis — IVF 42% live birth per cycle citation.
Medical disclaimer: This article provides educational information about PCOS and fertility based on published clinical research. It is not medical advice and is not a fertility treatment plan. Fertility decisions should be made in consultation with a reproductive endocrinologist, OB-GYN, or fertility specialist who can assess your individual clinical situation. Do not delay seeking medical advice based on information in this article.

Leave a Reply

Your email address will not be published. Required fields are marked *